Plasmacytic ALK-positive large B-cell lymphoma: A potential mimic of extramedullary plasmacytoma

Pathology International

Volumn 64, Issue 6, 2014, Pages 292-294

  Hashimoto, Taiki ^a   Fujimoto, Masakazu ^a   Nishikori, Momoko ^a   Takeuchi, Kengo ^b   Kimura, Mizuki ^a   Nakajima, Naoki ^a   Miyagawa Hayashino, Aya ^a   Takaori Kondo, Akifumi ^a   Haga, Hironori ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; METHOTREXATE; VINCRISTINE; ANAPLASTIC LYMPHOMA KINASE; PROTEIN TYROSINE KINASE;

ALK GENE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CANCER REGRESSION; CASE REPORT; CHILD; CHROMOSOME ANALYSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; LABORATORY TEST; LARGE CELL LYMPHOMA; LETTER; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PLASMACYTOMA; PRIORITY JOURNAL; TUMOR CELL; ADULT; DIFFERENTIAL DIAGNOSIS; LYMPHOMA, B-CELL; METABOLISM; PATHOLOGY;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPHOMA, B-CELL; PLASMACYTOMA; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84903125339     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12160     Document Type: Letter

References (10)

1. Swerdlow SH, Campo E, Harris NL etal., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Geneva: WHO Press, 2008.
2. Morgan EA, Nascimento AF. Anaplastic lymphoma kinase-positive large B-cell lymphoma: An underrecognized aggressive lymphoma. Adv Hematol 2012; 2012: 529572: 1-6.
3. Togashi Y, Soda M, Sakata S etal. KLC1-ALK: A novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only. PLoS One 2012; 7: e31323.
4. Van Roosbroeck K, Cools J, Dierickx D etal. ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions. Haematologica 2010; 95: 509-513.
5. Bedwell C, Rowe D, Moulton D, Jones G, Bown N, Bacon CM. Cytogenetically complex SEC31A-ALK fusions are recurrent in ALK-positive large B-cell lymphomas. Haematologica 2011; 96: 343-346.
6. Wang WY, Gu L, Liu WP, Li GD, Liu HJ, Ma ZG. ALK-positive extramedullary plasmacytoma with expression of the CLTC-ALK fusion transcript. Pathol Res Pract 2011; 207: 587-591.
7. Gascoyne RD, Lamant L, Martin-Subero JI etal. ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: Report of 6 cases. Blood 2003; 102: 2568-2573.
8. Delsol G, Lamant L, Mariamé B etal. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood 1997; 89: 1483-1490.
9. Takeuchi K, Soda M, Togashi Y etal. Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma. Haematologica 2011; 96: 464-467.
10. Lee SE, Kang SY, Takeuchi K, Ko YH. Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma. Hematol Oncol 2014. doi: 10.1002/hon.2125.